Liege, Belgium, 20 April 2021 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces the publication of its 2020 Annual Report and the invitation to its ordinary and extraordinary general meeting of securities holders. 2020 Annual Report The Annual Report which outlines Mithra’s achievements in 2020 includes the […]
About Mithra Pharmaceuticals
This author has yet to write their bio.Meanwhile lets just say that we are proud Mithra Pharmaceuticals contributed a whooping 210 entries.
Entries by Mithra Pharmaceuticals
15 April 2021, 22:30 CEST, Adelaide, Australia and Liege, Belgium: Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce that the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for the novel combined oral contraceptive Estelle® under the trademark Nextstellis® (15 […]
Budapest, Hungary – Liege, Belgium – 26 March 2021 – 13:15 CET – Gedeon Richter Plc. (“Richter”) and Mithra Pharmaceuticals (“Mithra”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for a novel combined oral contraceptive containing 15 mg estetrol (E4) […]
Strengthening of the financial resources and balance sheet structure via various funding transactions for an amount of EUR 260 million, diversifying the sources of financing Record cash position of EUR 138.7 million allowing the continuation of our Business Development strategy for Donesta® and R&D projects beyond Women’s Health, notably in Covid-19 treatment Licensing milestones from […]
First E4-based product approved internationally Canadian regulatory approval is the first in the world for the novel combined oral contraceptive Estelle® Innovative product developed by Mithra containing the unique native estrogen Estetrol (E4) and drospirenone (DRSP) Approval supported by two large multinational Phase 3 studies conducted in 3,725 women Commercial launch in Canada anticipated mid-summer […]
Liege, Belgium, 04 March 2021 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health announces that it will host a live webcast on Tuesday, 9 March 2021 at 09:30 CET to present its 2020 financial and operating results. The live webcast can be accessed on the Mithra website or by clicking here. To […]
Successful launch of Mithra’s hormonal contraceptive ring in Italy under the trademark Kirkos® Italy is the third largest European market and the fourth worldwide, with 2 million vaginal rings sold per year Mithra CDMO pursues the manufacturing of its Myring™ orders for new commercial launches planned for 2021 Liege, Belgium, 2 March 2021 – 7:30 […]
• Publication of an article on Estelle® endocrine and metabolic parameters in prestigious Contraception Journal • Article concludes on limited impact of Estelle® compared to Ethinylestradiol-based combined oral contraceptives • Estelle® filing on going in the U.S., Europe and Canada, with expected marketing authorization in H12021 Liege, Belgium, 9 February 2021– 7:30 CET – Mithra […]
Liege, Belgium, 4 February 2021 – 7:30 CET – Meeting this Wednesday evening, the Board of Directors of Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, heard François Fornieri following his indictment in the context of a file relating to functions he previously held in a company not related to Mithra.
Liege, Belgium, 21 January 2021 – 22:00 CET – Meeting this Thursday evening, the Board of Directors of Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, took note of the arrest warrant issued against François Fornieri in connection with duties he previously performed in a company not related to Mithra.
Rue Saint-Georges 5
Tel. : +32 (0)4 349 28 22
Fax : +32 (0)4 349 28 21
Email : email@example.com